SAN DIEGO, May 24, 2011 /PRNewswire/ — ResMed (NYSE: RMD) today released the ResMed Sleep Assessment app, a novel new app for iPhone that lets users record themselves during sleep. The app also ...

Resmed beat Wall Street estimates for third-quarter profit on Wednesday, driven by demand for its sleep apnea devices used to manage the common sleep disorder. January 30, 2025 ResMed beats ...

ResMed’s myAir, a program for CPAP users to track sleep apnea treatment, is now available in the U.S. The app can be used by those working with the ResMed Air10.

Now, ResMed is opening up its wallet once again, this time to buy out Mementor, a Leipzig-based company that’s building digital therapeutics with a focus on sleep medicine.